Extended Data Fig. 3: Biological assay using CRISPR-off at Flower exon 3 impacts Flower isoform expression. | Nature Biotechnology

Extended Data Fig. 3: Biological assay using CRISPR-off at Flower exon 3 impacts Flower isoform expression.

From: Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells

Extended Data Fig. 3: Biological assay using CRISPR-off at Flower exon 3 impacts Flower isoform expression.

A) A model depicts CRISPR-off strategy for hFwe exon 3. B) Agarose gel electrophoresis of Bi-sulfite-treated and untreated samples derived from WT stromal cells and two clones of CRISPR-off engineered stromal cells. Stromal cells of Clone 1 were co-transfected with CRISPR-off plasmids dCas9-KRAB, dCAS9-D3A-3L, sgRNA targeting hFwe exon 3. Stromal cells of Clone 2 were co- transfected with CRISPR-off plasmids dCas9-DNMT3A, dCAS9- DNMT3B, sgRNA targeting hFwe exon 3. To confirm DNA methylation, we performed Methylation- specific PCR in samples treated or untreated with bi- sulfite and run the products in agarose gels. C) Co-culture of WT tumor and stromal cells shows binding of LINC01914 to hFwe exon 3 DNA, high hFwe exon 3 DNA methylation, enrichment of splicing machinery and high expression of hFwe-Lose isoforms, in stromal cells. Co-culture of LINC01914 KO tumor cells and hFwe exon 3 CRISPR-off stromal cells show no binding of LINC01914 to hFwe exon 3, high DNA methylation, enrichment of splicing machinery at Flower exon 3, and high expression of Flower Lose.

Source data

Back to article page